Key result
CMR-derived LVGLS is independently linked to higher MACE risk in chronic aortic regurgitation.
Why the study?
The prognostic value of CMR feature tracking-derived left ventricular global longitudinal strain (FT-LVGLS) and its incremental value beyond the 2025 ESC/EACTS Class I/IIb surgical indications in chronic moderate to severe aortic regurgitation needed evaluation.
Does cardiac magnetic resonance feature tracking-derived left ventricular global longitudinal strain (FT-LVGLS) improve risk assessment and prediction of major adverse cardiac events in patients with chronic moderate to severe aortic regurgitation?
Cohort (n=707)
Does cardiac magnetic resonance feature tracking-derived left ventricular global longitudinal strain (FT-LVGLS) improve risk assessment and prediction of major adverse cardiac events in patients with chronic moderate to severe aortic regurgitation?
CMR-derived FT-LVGLS independently predicts adverse outcomes in chronic moderate-to-severe aortic regurgitation and provides incremental prognostic value beyond current ESC/EACTS surgical indications in patients with NYHA class I-II symptoms.
Objectives To evaluate the prognostic value of cardiac magnetic resonance (CMR) feature tracking-derived left ventricular global longitudinal strain (FT-LVGLS) for adverse outcomes in patients with chronic moderate to severe aortic regurgitation (AR), and to further assess its incremental prognostic value beyond the 2025 ESC/EACTS Class I/IIb surgical decision indications among a prespecified subgroup of patients with no or minimal symptoms (NYHA functional class I–II) who were potential candidates for aortic valve replacement. Methods This retrospective cohort study included 707 patients (mean age 54.5 ± 13.5 years; 593 male) with at least moderate chronic AR who underwent CMR between 2010 and 2024. The primary endpoint was major adverse cardiac events (MACE), defined as all-cause mortality, heart transplantation, rehospitalization for heart failure, or ICD discharge. Results During a median follow-up of 52.6 months, 152 patients experienced MACE. Multivariable Cox regression identified FT-LVGLS as an independent predictor of MACE (adjusted HR: 1.148 per 1% increase, P < .001). Among patients with NYHA class I-II, incorporating FT-LVGLS into models based on each ESC/EACTS Class I/IIb surgical indication significantly improved model discrimination, with higher C-index (from 0.739-0.747 to 0.775) and likelihood ratio χ² values (from 34.00-39.18 to 46.65-47.66). Kaplan-Meier survival curves demonstrated that a cutoff of -12% for FT-LVGLS further refined risk stratification. Conclusion FT-LVGLS independently predicted adverse outcomes in patients with chronic moderate-to-severe AR, providing incremental prognostic value beyond ESC/EACTS surgical indicators and improving risk identification.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) conducted a cohort in Chronic moderate to severe aortic regurgitation (n=707). CMR feature tracking-derived left ventricular global longitudinal strain (FT-LVGLS) vs. 2025 ESC/EACTS Class I/IIb surgical decision indications was evaluated on Major adverse cardiac events (MACE: all-cause mortality, heart transplantation, rehospitalization for heart failure, or ICD discharge) (adjusted HR 1.148 per 1% increase, p=< .001). CMR feature tracking-derived LVGLS independently predicted MACE in chronic moderate-to-severe aortic regurgitation (adjusted HR 1.148 per 1% increase, P<.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: